Duragesic and Palatal disorder - a phase IV clinical study of FDA data

Summary:

Palatal disorder is reported as a side effect among people who take Duragesic (fentanyl), especially for people who are female, 50-59 old, also take Linezolid, and have Breast cancer metastatic.

The phase IV clinical study analyzes which people have Palatal disorder when taking Duragesic. It is created by eHealthMe based on reports of 66,376 people who have side effects when taking Duragesic from the FDA, and is updated regularly.

What is Duragesic?

Duragesic has active ingredients of fentanyl. eHealthMe is studying from 66,597 Duragesic users. Check the latest studies of Duragesic.

What is Palatal disorder?

Palatal disorder is found to be associated with 156 drugs and 190 conditions by eHealthMe. Check the latest studies of Palatal disorder.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

66,376 people reported to have side effects when taking Duragesic.
Among them, 15 people (0.02%) have Palatal disorder.

Among these 15 people:

What is the gender of people who have Palatal disorder when taking Duragesic? *

female: 86.67 %
male: 13.33 %

What is the age of people who have Palatal disorder when taking Duragesic? *

What are other drugs people take besides Duragesic? *

What are other side effects people have besides Palatal disorder? *

Fever: 14 people, 93.33%
Wound Infection Staphylococcal: 13 people, 86.67%
Weight Decreased: 13 people, 86.67%
Enlarged Heart: 13 people, 86.67%
Flank Pain (a distressing sensation experienced around the lower back and the upper abdomen): 13 people, 86.67%
Gastric Ulcer (stomach ulcer): 13 people, 86.67%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 13 people, 86.67%
Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 13 people, 86.67%
Hypoaesthesia Oral (reduced sense of touch or sensation in mouth): 13 people, 86.67%
Muscle Spasms (muscle contraction): 13 people, 86.67%

What are the existing conditions these people have? *

Breast Cancer Metastatic: 11 people, 73.33%
Pain In Jaw: 2 people, 13.33%
Neoplasm Malignant (cancer tumour): 2 people, 13.33%
Respiratory Disorder (respiratory disease): 1 person, 6.67%
Lung Infection: 1 person, 6.67%
Ill-Defined Disorder: 1 person, 6.67%
Gout (uric acid crystals building up in the body): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Duragesic and have Palatal disorder?

- Check whether Palatal disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Duragesic:

Duragesic (66,597 reports)

Browse all side effects of Duragesic:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Palatal disorder:

Palatal disorder (156 drugs)

Browse all the conditions that are associated with Palatal disorder:

Palatal disorder (190 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on fentanyl (the active ingredients of Duragesic) and Duragesic (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.